ID   AOC3_HUMAN              Reviewed;         763 AA.
AC   Q16853; B2RCI5; K7ESB3; L0L8N9; Q45F94;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Membrane primary amine oxidase;
DE            EC=1.4.3.21 {ECO:0000269|PubMed:19588076};
DE   AltName: Full=Copper amine oxidase;
DE   AltName: Full=HPAO;
DE   AltName: Full=Semicarbazide-sensitive amine oxidase;
DE            Short=SSAO;
DE   AltName: Full=Vascular adhesion protein 1;
DE            Short=VAP-1;
GN   Name=AOC3; Synonyms=VAP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=8972912; DOI=10.1016/S0378-1119(96)00387-3;
RA   Zhang X., McIntire W.S.;
RT   "Cloning and sequencing of a copper-containing, topaquinone-containing
RT   monoamine oxidase from human placenta.";
RL   Gene 179:279-286(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE,
RP   FUNCTION, SELF-ASSOCIATION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Lung;
RX   PubMed=9653080; DOI=10.1084/jem.188.1.17;
RA   Smith D.J., Salmi M., Bono P., Hellman J., Leu T., Jalkanen S.;
RT   "Cloning of vascular adhesion protein 1 reveals a novel
RT   multifunctional adhesion molecule.";
RL   J. Exp. Med. 188:17-27(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=14585497; DOI=10.1016/S0378-1119(03)00753-4;
RA   Zhang Q., Mashima Y., Noda S., Imamura Y., Kudoh J., Shimizu N.,
RA   Nishiyama T., Umeda S., Oguchi Y., Tanaka Y., Iwata T.;
RT   "Characterization of AOC2 gene encoding a copper-binding amine oxidase
RT   expressed specifically in retina.";
RL   Gene 318:45-53(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBUNIT, ALTERNATIVE
RP   SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=23349812; DOI=10.1371/journal.pone.0054151;
RA   Kaitaniemi S., Gron K., Elovaara H., Salmi M., Jalkanen S., Elima K.;
RT   "Functional modulation of vascular adhesion protein-1 by a novel
RT   splice variant.";
RL   PLoS ONE 8:E54151-E54151(2013).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-5; TYR-167;
RP   THR-371; SER-408; HIS-426; TRP-441; THR-582; SER-700 AND VAL-749.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 79-90 AND 123-132.
RC   TISSUE=Adipocyte;
RX   PubMed=15242332; DOI=10.1042/BJ20040647;
RA   Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.;
RT   "Vectorial proteomics reveal targeting, phosphorylation and specific
RT   fragmentation of polymerase I and transcript release factor (PTRF) at
RT   the surface of caveolae in human adipocytes.";
RL   Biochem. J. 383:237-248(2004).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-592; ASN-618 AND ASN-666.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [11]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=17400359; DOI=10.1016/j.biochi.2007.02.013;
RA   Bour S., Daviaud D., Gres S., Lefort C., Prevot D., Zorzano A.,
RA   Wabitsch M., Saulnier-Blache J.-S., Valet P., Carpene C.;
RT   "Adipogenesis-related increase of semicarbazide-sensitive amine
RT   oxidase and monoamine oxidase in human adipocytes.";
RL   Biochimie 89:916-925(2007).
RN   [12]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, MUTAGENESIS OF
RP   MET-211; TYR-394 AND LEU-469, AND CATALYTIC ACTIVITY.
RX   PubMed=19588076; DOI=10.1007/s00018-009-0076-5;
RA   Kaitaniemi S., Elovaara H., Groen K., Kidron H., Liukkonen J.,
RA   Salminen T., Salmi M., Jalkanen S., Elima K.;
RT   "The unique substrate specificity of human AOC2, a semicarbazide-
RT   sensitive amine oxidase.";
RL   Cell. Mol. Life Sci. 66:2743-2757(2009).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-137; ASN-294; ASN-592;
RP   ASN-618 AND ASN-666.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [14]
RP   GLYCOSYLATION AT ASN-592.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [15] {ECO:0000244|PDB:1PU4, ECO:0000244|PDB:1US1}
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) IN COMPLEX WITH CALCIUM; COPPER
RP   AND SUBSTRATE, DISULFIDE BONDS, TOPAQUINONE AT TYR-471, AND
RP   GLYCOSYLATION AT ASN-137; THR-212; ASN-232; ASN-294; ASN-592; ASN-618
RP   AND ASN-666.
RX   PubMed=16046623; DOI=10.1110/ps.051438105;
RA   Airenne T.T., Nymalm Y., Kidron H., Smith D.J., Pihlavisto M.,
RA   Salmi M., Jalkanen S., Johnson M.S., Salminen T.A.;
RT   "Crystal structure of the human vascular adhesion protein-1: unique
RT   structural features with functional implications.";
RL   Protein Sci. 14:1964-1974(2005).
CC   -!- FUNCTION: Cell adhesion protein that participates in lymphocyte
CC       extravasation and recirculation by mediating the binding of
CC       lymphocytes to peripheral lymph node vascular endothelial cells in
CC       an L-selectin-independent fashion. Has semicarbazide-sensitive
CC       (SSAO) monoamine oxidase activity. May play a role in
CC       adipogenesis. {ECO:0000269|PubMed:17400359,
CC       ECO:0000269|PubMed:19588076, ECO:0000269|PubMed:23349812,
CC       ECO:0000269|PubMed:9653080}.
CC   -!- CATALYTIC ACTIVITY: RCH(2)NH(2) + H(2)O + O(2) = RCHO + NH(3) +
CC       H(2)O(2). {ECO:0000269|PubMed:19588076}.
CC   -!- COFACTOR:
CC       Name=Cu cation; Xref=ChEBI:CHEBI:23378;
CC         Evidence={ECO:0000269|PubMed:16046623};
CC       Note=Binds 1 copper ion per subunit.
CC       {ECO:0000269|PubMed:16046623};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:16046623};
CC       Note=Binds 2 calcium ions per subunit.
CC       {ECO:0000269|PubMed:16046623};
CC   -!- COFACTOR:
CC       Name=L-topaquinone; Xref=ChEBI:CHEBI:79027;
CC         Evidence={ECO:0000269|PubMed:16046623};
CC       Note=Contains 1 topaquinone per subunit.
CC       {ECO:0000269|PubMed:16046623};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.94 mM for 2-phenylethylamine {ECO:0000269|PubMed:19588076};
CC         KM=0.67 mM for methylamine {ECO:0000269|PubMed:19588076};
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Can heterodimerize with
CC       isoform 2 leading to reduced surface expression. Forms a
CC       heterodimer with AOC2. {ECO:0000269|PubMed:16046623,
CC       ECO:0000269|PubMed:19588076, ECO:0000269|PubMed:23349812}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9653080};
CC       Single-pass type II membrane protein {ECO:0000269|PubMed:9653080}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q16853-1; Sequence=Displayed;
CC       Name=2; Synonyms=VAP-1Delta3;
CC         IsoId=Q16853-2; Sequence=VSP_053751, VSP_053752;
CC         Note=Devoid of the semicarbazide-sensitive amine oxidase (SSAO)
CC         activity.;
CC       Name=3;
CC         IsoId=Q16853-3; Sequence=VSP_055201;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Strongly expressed on the high endothelial
CC       venules of peripheral lymph nodes and on hepatic endothelia. Also
CC       highly expressed in appendix, lung and small intestine. Expressed
CC       also in adipose tissue, in bone marrow, colon, heart, kidney,
CC       ovary, pancreas, placenta, prostate, skeletal muscle, spleen and
CC       testis. Isoform 2 seems to be the predominant transcript in fetal
CC       kidneys, fetal cartilage and fetal tonsils. The highest relative
CC       expression of isoform 2 occurs in skeletal muscle, heart,
CC       pancreas, kidney, and lung. {ECO:0000269|PubMed:17400359,
CC       ECO:0000269|PubMed:23349812, ECO:0000269|PubMed:9653080}.
CC   -!- INDUCTION: Up-regulated during in vitro adipocyte differentiation.
CC       {ECO:0000269|PubMed:17400359}.
CC   -!- PTM: Topaquinone (TPQ) is generated by copper-dependent
CC       autoxidation of a specific tyrosyl residue.
CC       {ECO:0000269|PubMed:16046623}.
CC   -!- PTM: N- and O-glycosylated. {ECO:0000269|PubMed:16046623,
CC       ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19139490,
CC       ECO:0000269|PubMed:19159218}.
CC   -!- SIMILARITY: Belongs to the copper/topaquinone oxidase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/aoc3/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U39447; AAC50919.1; -; mRNA.
DR   EMBL; AF067406; AAC25170.1; -; mRNA.
DR   EMBL; AB050502; BAB18866.1; -; Genomic_DNA.
DR   EMBL; JX020506; AGB67480.1; -; mRNA.
DR   EMBL; AK025727; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK315129; BAG37582.1; -; mRNA.
DR   EMBL; DQ143944; AAZ38716.1; -; Genomic_DNA.
DR   EMBL; AC016889; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC050549; AAH50549.1; -; mRNA.
DR   CCDS; CCDS11444.1; -. [Q16853-1]
DR   CCDS; CCDS62198.1; -. [Q16853-3]
DR   CCDS; CCDS74071.1; -. [Q16853-2]
DR   PIR; JC5234; JC5234.
DR   RefSeq; NP_001264660.1; NM_001277731.1. [Q16853-2]
DR   RefSeq; NP_001264661.1; NM_001277732.1. [Q16853-3]
DR   RefSeq; NP_003725.1; NM_003734.3. [Q16853-1]
DR   UniGene; Hs.198241; -.
DR   PDB; 1PU4; X-ray; 3.20 A; A/B=1-763.
DR   PDB; 1US1; X-ray; 2.90 A; A/B=1-763.
DR   PDB; 2C10; X-ray; 2.50 A; A/B/C/D=29-763.
DR   PDB; 2C11; X-ray; 2.90 A; A/B/C/D=29-763.
DR   PDB; 2Y73; X-ray; 2.60 A; A/B=1-763.
DR   PDB; 2Y74; X-ray; 2.95 A; A/B=1-763.
DR   PDB; 3ALA; X-ray; 2.90 A; A/B/C/D/E/F/G=33-763.
DR   PDB; 4BTW; X-ray; 2.80 A; A/B=27-763.
DR   PDB; 4BTX; X-ray; 2.78 A; A/B=27-763.
DR   PDB; 4BTY; X-ray; 3.10 A; A/B=27-763.
DR   PDBsum; 1PU4; -.
DR   PDBsum; 1US1; -.
DR   PDBsum; 2C10; -.
DR   PDBsum; 2C11; -.
DR   PDBsum; 2Y73; -.
DR   PDBsum; 2Y74; -.
DR   PDBsum; 3ALA; -.
DR   PDBsum; 4BTW; -.
DR   PDBsum; 4BTX; -.
DR   PDBsum; 4BTY; -.
DR   ProteinModelPortal; Q16853; -.
DR   SMR; Q16853; -.
DR   BioGrid; 114192; 8.
DR   IntAct; Q16853; 5.
DR   STRING; 9606.ENSP00000312326; -.
DR   BindingDB; Q16853; -.
DR   ChEMBL; CHEMBL3437; -.
DR   DrugBank; DB04334; 6-hydroxydopa quinone.
DR   DrugBank; DB01275; Hydralazine.
DR   DrugBank; DB00780; Phenelzine.
DR   GuidetoPHARMACOLOGY; 2767; -.
DR   iPTMnet; Q16853; -.
DR   PhosphoSitePlus; Q16853; -.
DR   DMDM; 2501336; -.
DR   PaxDb; Q16853; -.
DR   PeptideAtlas; Q16853; -.
DR   PRIDE; Q16853; -.
DR   Ensembl; ENST00000308423; ENSP00000312326; ENSG00000131471. [Q16853-1]
DR   Ensembl; ENST00000591562; ENSP00000468632; ENSG00000131471. [Q16853-3]
DR   Ensembl; ENST00000613571; ENSP00000484312; ENSG00000131471. [Q16853-2]
DR   Ensembl; ENST00000617500; ENSP00000477686; ENSG00000131471. [Q16853-3]
DR   GeneID; 8639; -.
DR   KEGG; hsa:8639; -.
DR   UCSC; uc002ibv.6; human. [Q16853-1]
DR   CTD; 8639; -.
DR   DisGeNET; 8639; -.
DR   GeneCards; AOC3; -.
DR   HGNC; HGNC:550; AOC3.
DR   HPA; CAB025797; -.
DR   HPA; HPA000980; -.
DR   MIM; 603735; gene.
DR   neXtProt; NX_Q16853; -.
DR   OpenTargets; ENSG00000131471; -.
DR   PharmGKB; PA24840; -.
DR   eggNOG; KOG1186; Eukaryota.
DR   eggNOG; COG3733; LUCA.
DR   GeneTree; ENSGT00510000046461; -.
DR   HOGENOM; HOG000233919; -.
DR   HOVERGEN; HBG004164; -.
DR   InParanoid; Q16853; -.
DR   KO; K00276; -.
DR   OMA; DEGRFNW; -.
DR   OrthoDB; EOG091G02WY; -.
DR   PhylomeDB; Q16853; -.
DR   TreeFam; TF314750; -.
DR   BRENDA; 1.4.3.21; 2681.
DR   Reactome; R-HSA-211945; Phase 1 - Functionalization of compounds.
DR   SABIO-RK; Q16853; -.
DR   EvolutionaryTrace; Q16853; -.
DR   GeneWiki; AOC3; -.
DR   GenomeRNAi; 8639; -.
DR   PRO; PR:Q16853; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000131471; -.
DR   CleanEx; HS_AOC3; -.
DR   ExpressionAtlas; Q16853; baseline and differential.
DR   Genevisible; Q16853; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005769; C:early endosome; IDA:CACAO.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:CACAO.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:CACAO.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005902; C:microvillus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0052595; F:aliphatic-amine oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052594; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; IEA:UniProtKB-EC.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0005507; F:copper ion binding; IDA:UniProtKB.
DR   GO; GO:0052596; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; IEA:UniProtKB-EC.
DR   GO; GO:0008131; F:primary amine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; TAS:UniProtKB.
DR   GO; GO:0048038; F:quinone binding; IDA:UniProtKB.
DR   GO; GO:0052593; F:tryptamine:oxygen oxidoreductase (deaminating) activity; IEA:UniProtKB-EC.
DR   GO; GO:0009308; P:amine metabolic process; IDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IDA:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
DR   GO; GO:1902283; P:negative regulation of primary amine oxidase activity; IDA:UniProtKB.
DR   GO; GO:0046677; P:response to antibiotic; IDA:UniProtKB.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   Gene3D; 2.70.98.20; -; 1.
DR   InterPro; IPR000269; Cu_amine_oxidase.
DR   InterPro; IPR015798; Cu_amine_oxidase_C.
DR   InterPro; IPR016182; Cu_amine_oxidase_N-reg.
DR   InterPro; IPR015800; Cu_amine_oxidase_N2.
DR   InterPro; IPR015802; Cu_amine_oxidase_N3.
DR   PANTHER; PTHR10638; PTHR10638; 1.
DR   Pfam; PF01179; Cu_amine_oxid; 1.
DR   Pfam; PF02727; Cu_amine_oxidN2; 1.
DR   Pfam; PF02728; Cu_amine_oxidN3; 1.
DR   PRINTS; PR00766; CUDAOXIDASE.
DR   SUPFAM; SSF49998; SSF49998; 1.
DR   SUPFAM; SSF54416; SSF54416; 2.
DR   PROSITE; PS01164; COPPER_AMINE_OXID_1; 1.
DR   PROSITE; PS01165; COPPER_AMINE_OXID_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell adhesion;
KW   Cell membrane; Complete proteome; Copper; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Membrane; Metal-binding; Oxidoreductase;
KW   Polymorphism; Reference proteome; Signal-anchor; TPQ; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:O08590}.
FT   CHAIN         2    763       Membrane primary amine oxidase.
FT                                /FTId=PRO_0000064102.
FT   TOPO_DOM      2      5       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      6     26       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     27    763       Extracellular. {ECO:0000255}.
FT   REGION      384    394       Substrate binding.
FT                                {ECO:0000244|PDB:4BTY}.
FT   REGION      468    473       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P19801}.
FT   ACT_SITE    386    386       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:P19801}.
FT   ACT_SITE    471    471       Schiff-base intermediate with substrate;
FT                                via topaquinone. {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2Y73}.
FT   METAL       520    520       Copper; via tele nitrogen.
FT                                {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY,
FT                                ECO:0000269|PubMed:16046623}.
FT   METAL       522    522       Copper; via tele nitrogen.
FT                                {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY,
FT                                ECO:0000269|PubMed:16046623}.
FT   METAL       529    529       Calcium 1. {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY}.
FT   METAL       530    530       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY}.
FT   METAL       531    531       Calcium 1. {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY}.
FT   METAL       572    572       Calcium 2. {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY}.
FT   METAL       638    638       Calcium 2. {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C11}.
FT   METAL       641    641       Calcium 2. {ECO:0000244|PDB:4BTW}.
FT   METAL       663    663       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY}.
FT   METAL       665    665       Calcium 2. {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY}.
FT   METAL       667    667       Calcium 2. {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY}.
FT   METAL       673    673       Calcium 1. {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY}.
FT   METAL       674    674       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY}.
FT   METAL       684    684       Copper; via pros nitrogen.
FT                                {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY,
FT                                ECO:0000269|PubMed:16046623}.
FT   MOD_RES     471    471       2',4',5'-topaquinone.
FT                                {ECO:0000244|PDB:1PU4}.
FT   CARBOHYD    137    137       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY,
FT                                ECO:0000269|PubMed:16046623,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    212    212       O-linked (GalNAc...) threonine.
FT                                {ECO:0000305|PubMed:16046623}.
FT   CARBOHYD    232    232       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1PU4,
FT                                ECO:0000244|PDB:1US1,
FT                                ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY,
FT                                ECO:0000269|PubMed:16046623}.
FT   CARBOHYD    294    294       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:4BTY,
FT                                ECO:0000269|PubMed:16046623,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    592    592       N-linked (GlcNAc...) (complex)
FT                                asparagine. {ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:3ALA,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY,
FT                                ECO:0000269|PubMed:16046623,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    618    618       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000269|PubMed:16046623,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    666    666       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:2C10,
FT                                ECO:0000244|PDB:2C11,
FT                                ECO:0000244|PDB:2Y73,
FT                                ECO:0000244|PDB:2Y74,
FT                                ECO:0000244|PDB:4BTW,
FT                                ECO:0000244|PDB:4BTX,
FT                                ECO:0000244|PDB:4BTY,
FT                                ECO:0000269|PubMed:16046623,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   DISULFID    198    199       {ECO:0000269|PubMed:16046623}.
FT   DISULFID    404    430       {ECO:0000250|UniProtKB:P19801}.
FT   DISULFID    734    741       {ECO:0000269|PubMed:16046623}.
FT   DISULFID    748    748       Interchain.
FT                                {ECO:0000269|PubMed:16046623}.
FT   VAR_SEQ       1    543       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055201.
FT   VAR_SEQ     630    634       YQLAV -> IWWPG (in isoform 2).
FT                                {ECO:0000303|PubMed:23349812}.
FT                                /FTId=VSP_053751.
FT   VAR_SEQ     635    763       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:23349812}.
FT                                /FTId=VSP_053752.
FT   VARIANT       5      5       T -> R (in dbSNP:rs33954211).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025035.
FT   VARIANT      78     78       R -> Q (in dbSNP:rs402680).
FT                                /FTId=VAR_052603.
FT   VARIANT     167    167       H -> Y (in dbSNP:rs2228470).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025027.
FT   VARIANT     171    171       V -> M (in dbSNP:rs408038).
FT                                /FTId=VAR_052604.
FT   VARIANT     203    203       H -> R (in dbSNP:rs630079).
FT                                /FTId=VAR_052605.
FT   VARIANT     317    317       Y -> H (in dbSNP:rs438287).
FT                                /FTId=VAR_012064.
FT   VARIANT     329    329       R -> Q (in dbSNP:rs2229595).
FT                                /FTId=VAR_024343.
FT   VARIANT     371    371       I -> T (in dbSNP:rs35097308).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025028.
FT   VARIANT     408    408       A -> S (in dbSNP:rs35643019).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025029.
FT   VARIANT     426    426       R -> H (in dbSNP:rs33986943).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025030.
FT   VARIANT     441    441       R -> W (in dbSNP:rs2229596).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025031.
FT   VARIANT     582    582       A -> T (in dbSNP:rs34987927).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025032.
FT   VARIANT     700    700       G -> S (in dbSNP:rs477207).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025033.
FT   VARIANT     749    749       A -> V (in dbSNP:rs34012919).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025034.
FT   MUTAGEN     211    211       M->V: Increased activity towards 2-
FT                                phenylethylamine, and decreased activity
FT                                towards methylamine; when associated with
FT                                N-394 and G-469.
FT                                {ECO:0000269|PubMed:19588076}.
FT   MUTAGEN     394    394       Y->N: Increased activity towards 2-
FT                                phenylethylamine, and decreased activity
FT                                towards methylamine; when associated with
FT                                V-211 and G-469.
FT                                {ECO:0000269|PubMed:19588076}.
FT   MUTAGEN     469    469       L->G: Increased activity towards 2-
FT                                phenylethylamine, and decreased activity
FT                                towards methylamine; when associated with
FT                                V-211 and N-394.
FT                                {ECO:0000269|PubMed:19588076}.
FT   HELIX        65     78       {ECO:0000244|PDB:2C10}.
FT   STRAND       83     85       {ECO:0000244|PDB:3ALA}.
FT   HELIX        86     88       {ECO:0000244|PDB:2C10}.
FT   STRAND       93    102       {ECO:0000244|PDB:2C10}.
FT   HELIX       106    115       {ECO:0000244|PDB:2C10}.
FT   STRAND      123    130       {ECO:0000244|PDB:2C10}.
FT   STRAND      132    135       {ECO:0000244|PDB:2C10}.
FT   STRAND      137    144       {ECO:0000244|PDB:2C10}.
FT   STRAND      146    148       {ECO:0000244|PDB:2C10}.
FT   STRAND      151    154       {ECO:0000244|PDB:2C10}.
FT   HELIX       156    160       {ECO:0000244|PDB:2C10}.
FT   HELIX       166    168       {ECO:0000244|PDB:2C10}.
FT   HELIX       173    185       {ECO:0000244|PDB:2C10}.
FT   HELIX       188    191       {ECO:0000244|PDB:2C10}.
FT   HELIX       192    199       {ECO:0000244|PDB:2C10}.
FT   TURN        203    206       {ECO:0000244|PDB:2C11}.
FT   STRAND      208    211       {ECO:0000244|PDB:2C10}.
FT   STRAND      217    219       {ECO:0000244|PDB:2C10}.
FT   STRAND      224    231       {ECO:0000244|PDB:2C10}.
FT   STRAND      234    236       {ECO:0000244|PDB:2C10}.
FT   HELIX       238    240       {ECO:0000244|PDB:2C10}.
FT   STRAND      242    250       {ECO:0000244|PDB:2C10}.
FT   STRAND      253    255       {ECO:0000244|PDB:2C10}.
FT   HELIX       256    258       {ECO:0000244|PDB:2C10}.
FT   STRAND      260    266       {ECO:0000244|PDB:2C10}.
FT   STRAND      269    272       {ECO:0000244|PDB:2C10}.
FT   HELIX       274    282       {ECO:0000244|PDB:2C10}.
FT   TURN        283    285       {ECO:0000244|PDB:4BTW}.
FT   TURN        298    300       {ECO:0000244|PDB:2C10}.
FT   STRAND      314    316       {ECO:0000244|PDB:2C10}.
FT   STRAND      318    320       {ECO:0000244|PDB:4BTW}.
FT   STRAND      322    326       {ECO:0000244|PDB:2C10}.
FT   STRAND      329    342       {ECO:0000244|PDB:2C10}.
FT   TURN        343    345       {ECO:0000244|PDB:2C10}.
FT   STRAND      346    354       {ECO:0000244|PDB:2C10}.
FT   STRAND      357    372       {ECO:0000244|PDB:2C10}.
FT   HELIX       377    380       {ECO:0000244|PDB:2C10}.
FT   STRAND      383    385       {ECO:0000244|PDB:2C10}.
FT   HELIX       386    388       {ECO:0000244|PDB:2C10}.
FT   TURN        391    394       {ECO:0000244|PDB:2C10}.
FT   TURN        400    402       {ECO:0000244|PDB:2C10}.
FT   STRAND      408    421       {ECO:0000244|PDB:2C10}.
FT   STRAND      423    445       {ECO:0000244|PDB:2C10}.
FT   STRAND      447    449       {ECO:0000244|PDB:2C10}.
FT   STRAND      451    468       {ECO:0000244|PDB:2C10}.
FT   STRAND      471    479       {ECO:0000244|PDB:2C10}.
FT   TURN        481    483       {ECO:0000244|PDB:4BTY}.
FT   STRAND      485    493       {ECO:0000244|PDB:2C10}.
FT   STRAND      497    499       {ECO:0000244|PDB:2C10}.
FT   STRAND      506    512       {ECO:0000244|PDB:2C10}.
FT   STRAND      515    518       {ECO:0000244|PDB:2C10}.
FT   STRAND      520    530       {ECO:0000244|PDB:2C10}.
FT   STRAND      534    551       {ECO:0000244|PDB:2C10}.
FT   STRAND      554    569       {ECO:0000244|PDB:2C10}.
FT   HELIX       572    575       {ECO:0000244|PDB:2C10}.
FT   STRAND      577    581       {ECO:0000244|PDB:4BTW}.
FT   STRAND      585    594       {ECO:0000244|PDB:2C10}.
FT   STRAND      600    608       {ECO:0000244|PDB:2C10}.
FT   STRAND      617    619       {ECO:0000244|PDB:2C11}.
FT   HELIX       622    629       {ECO:0000244|PDB:2C10}.
FT   STRAND      630    636       {ECO:0000244|PDB:2C10}.
FT   TURN        647    651       {ECO:0000244|PDB:2Y73}.
FT   STRAND      653    655       {ECO:0000244|PDB:1US1}.
FT   HELIX       660    663       {ECO:0000244|PDB:2C10}.
FT   STRAND      670    684       {ECO:0000244|PDB:2C10}.
FT   HELIX       688    690       {ECO:0000244|PDB:2C10}.
FT   STRAND      700    713       {ECO:0000244|PDB:2C10}.
FT   HELIX       715    718       {ECO:0000244|PDB:2C10}.
FT   STRAND      723    729       {ECO:0000244|PDB:2C10}.
FT   TURN        734    736       {ECO:0000244|PDB:2C10}.
FT   HELIX       738    741       {ECO:0000244|PDB:2Y73}.
FT   HELIX       742    745       {ECO:0000244|PDB:2C10}.
SQ   SEQUENCE   763 AA;  84622 MW;  58AD55605EC9D228 CRC64;
     MNQKTILVLL ILAVITIFAL VCVLLVGRGG DGGEPSQLPH CPSVSPSAQP WTHPGQSQLF
     ADLSREELTA VMRFLTQRLG PGLVDAAQAR PSDNCVFSVE LQLPPKAAAL AHLDRGSPPP
     AREALAIVFF GRQPQPNVSE LVVGPLPHPS YMRDVTVERH GGPLPYHRRP VLFQEYLDID
     QMIFNRELPQ ASGLLHHCCF YKHRGRNLVT MTTAPRGLQS GDRATWFGLY YNISGAGFFL
     HHVGLELLVN HKALDPARWT IQKVFYQGRY YDSLAQLEAQ FEAGLVNVVL IPDNGTGGSW
     SLKSPVPPGP APPLQFYPQG PRFSVQGSRV ASSLWTFSFG LGAFSGPRIF DVRFQGERLV
     YEISLQEALA IYGGNSPAAM TTRYVDGGFG MGKYTTPLTR GVDCPYLATY VDWHFLLESQ
     APKTIRDAFC VFEQNQGLPL RRHHSDLYSH YFGGLAETVL VVRSMSTLLN YDYVWDTVFH
     PSGAIEIRFY ATGYISSAFL FGATGKYGNQ VSEHTLGTVH THSAHFKVDL DVAGLENWVW
     AEDMVFVPMA VPWSPEHQLQ RLQVTRKLLE MEEQAAFLVG SATPRYLYLA SNHSNKWGHP
     RGYRIQMLSF AGEPLPQNSS MARGFSWERY QLAVTQRKEE EPSSSSVFNQ NDPWAPTVDF
     SDFINNETIA GKDLVAWVTA GFLHIPHAED IPNTVTVGNG VGFFLRPYNF FDEDPSFYSA
     DSIYFRGDQD AGACEVNPLA CLPQAAACAP DLPAFSHGGF SHN
//
